Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Dynavax Technologies Cash on Hand 2006-2019 | DVAX

Dynavax Technologies cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  
Dynavax Technologies Annual Cash on Hand
(Millions of US $)
2018 $146
2017 $192
2016 $81
2015 $196
2014 $123
2013 $189
2012 $125
2011 $114
2010 $72
2009 $37
2008 $69
2007 $89
2006 $87
2005 $76
Dynavax Technologies Quarterly Cash on Hand
(Millions of US $)
Q2 2019 $140
Q1 2019 $183
Q4 2018 $146
Q3 2018 $180
Q2 2018 $216
Q1 2018 $251
Q4 2017 $192
Q3 2017 $192
Q2 2017 $127
Q1 2017 $85
Q4 2016 $81
Q3 2016 $110
Q2 2016 $139
Q1 2016 $167
Q4 2015 $196
Q3 2015 $221
Q2 2015 $93
Q1 2015 $98
Q4 2014 $123
Q3 2014 $131
Q2 2014 $154
Q1 2014 $178
Q4 2013 $189
Q3 2013 $76
Q2 2013 $89
Q1 2013 $105
Q4 2012 $125
Q3 2012 $148
Q2 2012 $160
Q1 2012 $107
Q4 2011 $114
Q3 2011 $53
Q2 2011 $62
Q1 2011 $53
Q4 2010 $72
Q3 2010 $48
Q2 2010 $58
Q1 2010 $31
Q4 2009 $37
Q3 2009 $47
Q2 2009 $54
Q1 2009 $61
Q4 2008 $69
Q3 2008 $65
Q2 2008 $64
Q1 2008 $74
Q4 2007 $89
Q3 2007 $69
Q2 2007 $83
Q1 2007 $72
Q4 2006 $87
Q3 2006 $59
Q2 2006 $61
Q1 2006 $68
Q4 2005 $76
Q3 2005 $51
Q2 2005 $59
Q1 2005 $58
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.260B $0.008B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.351B 13.94
Gilead Sciences (GILD) United States $79.964B 9.82
Celgene (CELG) United States $67.146B 10.39
Vertex Pharmaceuticals (VRTX) United States $47.536B 51.37
Biogen (BIIB) United States $42.733B 7.59
Illumina (ILMN) United States $42.067B 49.42
CSL (CSLLY) Australia $35.043B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.603B 14.80
Alexion Pharmaceuticals (ALXN) United States $24.856B 13.10
Incyte (INCY) United States $17.876B 52.61
Exact Sciences (EXAS) United States $15.515B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.729B 0.00
Seattle Genetics (SGEN) United States $12.808B 0.00
Genmab (GNMSF) Denmark $12.376B 62.91
Guardant Health (GH) United States $9.438B 0.00
Sarepta Therapeutics (SRPT) United States $9.289B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.973B 0.00
Galapagos (GLPG) Belgium $8.822B 0.00
QIAGEN (QGEN) Netherlands $7.800B 25.62
Bio-Techne Corp (TECH) United States $7.483B 51.72
BeiGene (BGNE) Cayman Islands $6.826B 0.00
Bluebird Bio (BLUE) United States $6.633B 0.00
Exelixis (EXEL) United States $6.579B 17.10
Amarin (AMRN) Ireland $5.412B 0.00
Horizon Pharma Public (HZNP) Ireland $5.034B 12.80
Ascendis Pharma (ASND) Denmark $4.822B 0.00
Repligen (RGEN) United States $4.774B 92.64
ARGENX SE-ADR (ARGX) Netherlands $4.379B 0.00
Moderna (MRNA) United States $4.345B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.278B 0.00
Blueprint Medicines (BPMC) United States $4.129B 0.00
China Biologic Products (CBPO) China $3.889B 24.27
Spark Therapeutics (ONCE) United States $3.871B 0.00
MorphoSys AG (MOR) Germany $3.793B 0.00
Mirati Therapeutics (MRTX) United States $3.620B 0.00
Alkermes (ALKS) Ireland $3.402B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.384B 0.00
Immunomedics (IMMU) United States $2.868B 0.00
Genomic Health (GHDX) United States $2.783B 52.20
Arena Pharmaceuticals (ARNA) United States $2.776B 5.97
Amicus Therapeutics (FOLD) United States $2.640B 0.00
NeoGenomics (NEO) United States $2.621B 140.22
CRISPR Therapeutics AG (CRSP) Switzerland $2.599B 0.00
Medicines (MDCO) United States $2.596B 0.00
MyoKardia (MYOK) United States $2.487B 0.00
Acceleron Pharma (XLRN) United States $2.424B 0.00
Halozyme Therapeutics (HALO) United States $2.382B 0.00
Reata Pharmaceuticals (RETA) United States $2.280B 0.00
Emergent Biosolutions (EBS) United States $2.252B 33.84
UniQure (QURE) Netherlands $2.154B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.093B 0.00
Cambrex (CBM) United States $2.016B 25.49
Akcea Therapeutics (AKCA) United States $1.980B 0.00
Zai Lab (ZLAB) China $1.960B 0.00
Myriad Genetics (MYGN) United States $1.873B 19.65
Ligand Pharmaceuticals (LGND) United States $1.805B 22.82
Denali Therapeutics (DNLI) United States $1.740B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.673B 0.00
Insmed (INSM) United States $1.481B 0.00
RA PHARMCTL INC (RARX) United States $1.383B 0.00
REGENXBIO (RGNX) United States $1.368B 0.00
AnaptysBio (ANAB) United States $1.331B 0.00
Coherus BioSciences (CHRS) United States $1.317B 0.00
Sangamo Therapeutics (SGMO) United States $1.313B 0.00
Editas Medicine (EDIT) United States $1.270B 0.00
Epizyme (EPZM) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.214B 0.00
Athenex (ATNX) United States $1.190B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.186B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.182B 0.00
Innoviva (INVA) United States $1.162B 3.36
Zymeworks (ZYME) Canada $1.034B 0.00
Alector (ALEC) United States $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.982B 0.00
Twist Bioscience (TWST) United States $0.965B 0.00
Cara Therapeutics (CARA) United States $0.928B 0.00
Principia Biopharma (PRNB) United States $0.892B 465.13
Adverum Biotechnologies (ADVM) United States $0.864B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
Intellia Therapeutics (NTLA) United States $0.845B 0.00
ANI Pharmaceuticals (ANIP) United States $0.829B 13.85
ZIOPHARM Oncology Inc (ZIOP) United States $0.823B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.809B 29.21
Arvinas (ARVN) United States $0.806B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.802B 0.00
Codexis (CDXS) United States $0.781B 0.00
Cytokineticsorporated (CYTK) United States $0.778B 0.00
Anika Therapeutics (ANIK) United States $0.775B 27.42
Retrophin (RTRX) United States $0.765B 0.00
WAVE Life Sciences (WVE) Singapore $0.732B 0.00
Pharming Group (PHGUF) Netherlands $0.730B 0.00
Vericel (VCEL) United States $0.720B 0.00
Stemline Therapeutics (STML) United States $0.670B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.666B 0.00
Zealand Pharma (ZLDPF) Denmark $0.664B 0.00
Zealand Pharma (ZEAL) Denmark $0.651B 7.55
Heska (HSKA) United States $0.569B 73.68
MiMedx (MDXG) United States $0.559B 0.00
DBV Technologies S.A (DBVT) France $0.542B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.516B 0.00
Cellectis S.A (CLLS) France $0.511B 0.00
Intra-Cellular Therapies (ITCI) United States $0.502B 0.00
Revance Therapeutics (RVNC) United States $0.500B 0.00
Precision BioSciences (DTIL) United States $0.474B 0.00
Syros Pharmaceuticals (SYRS) United States $0.470B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Mesoblast (MESO) Australia $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
CytomX Therapeutics (CTMX) United States $0.424B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.389B 0.00
Agenus (AGEN) United States $0.389B 0.00
PHARMA MAR SA (PHMMF) Spain $0.385B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.385B 0.00
Merus (MRUS) Netherlands $0.383B 0.00
Avid Bioservices (CDMO) United States $0.371B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
AC Immune SA (ACIU) Switzerland $0.363B 26.90
Gritstone Oncology (GRTS) United States $0.350B 0.00
Arcus Biosciences (RCUS) United States $0.338B 0.00
Kadmon Holdings (KDMN) United States $0.324B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Scholar Rock Holding (SRRK) United States $0.318B 0.00
Theratechnologies (THERF) Canada $0.312B 0.00
Prothena (PRTA) Ireland $0.309B 0.00
Clovis Oncology (CLVS) United States $0.306B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.297B 0.00
Sorrento Therapeutics (SRNE) United States $0.293B 0.00
PDL BioPharma (PDLI) United States $0.292B 7.53
Kindred Biosciences (KIN) United States $0.284B 0.00
Cel-Sci (CVM) United States $0.284B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.278B 0.00
Protagonist Therapeutics (PTGX) United States $0.269B 0.00
Geron (GERN) United States $0.266B 0.00
Cellular Biomedicine (CBMG) United States $0.260B 0.00
Senesco Technologies (ELOX) United States $0.249B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.247B 0.00
ChromaDex (CDXC) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.234B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Pfenex (PFNX) United States $0.220B 0.00
Kamada (KMDA) Israel $0.214B 8.17
Five Prime Therapeutics (FPRX) United States $0.214B 0.00
PHASEBIO PHARMA (PHAS) United States $0.212B 0.00
Prometic Life Sciences (PFSCF) Canada $0.210B 0.00
Seres Therapeutics (MCRB) United States $0.208B 0.00
MannKind (MNKD) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Palatin Technologies (PTN) United States $0.201B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Compugen (CGEN) Israel $0.194B 0.00
CorMedix Inc (CRMD) United States $0.193B 0.00
Spero Therapeutics (SPRO) United States $0.189B 0.00
Novavax (NVAX) United States $0.188B 0.00
Cue Biopharma (CUE) United States $0.180B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.171B 0.00
Affimed (AFMD) Germany $0.170B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) $0.163B 0.00
Arsanis (XFOR) United States $0.163B 0.00
Emmaus Life Sciences (EMMA) United States $0.156B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.155B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
BioTime (LCTX) United States $0.154B 10.30
Enzo Biochem (ENZ) United States $0.153B 0.00
Cerecor (CERC) United States $0.151B 0.00
Alcobra (ARCT) United States $0.151B 0.00
XOMA (XOMA) United States $0.149B 0.00
Nicox SA (NICXF) France $0.147B 0.00
Synlogic (SYBX) United States $0.146B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.146B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Strongbridge Biopharma (SBBP) United States $0.137B 5.62
Acorda Therapeutics (ACOR) United States $0.130B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
Northwest Biotherapeutics (NWBO) United States $0.125B 0.00
Windtree Therapeutics (WINT) United States $0.125B 0.00
NantKwest (NK) United States $0.123B 0.00
Celyad SA (CYAD) Belgium $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.113B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.113B 0.00
Liquidia Technologies (LQDA) United States $0.112B 0.00
Aduro Biotech (ADRO) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Abeona Therapeutics (ABEO) United States $0.109B 0.00
Aptinyx (APTX) United States $0.108B 0.00
TOCAGEN INC (TOCA) United States $0.108B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.104B 0.00
Verastem (VSTM) United States $0.095B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.094B 0.00
OvaScience (MLND) United States $0.094B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Arbutus Biopharma (ABUS) Canada $0.085B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Catalyst Biosciences (CBIO) United States $0.083B 0.00
Menlo Therapeutics (MNLO) United States $0.082B 0.00
Trevena (TRVN) United States $0.082B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
ARAVIVE, INC (ARAV) United States $0.071B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
VBI Vaccines (VBIV) United States $0.067B 0.00
Curis (CRIS) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Antibe Therapeutics (ATBPF) Canada $0.065B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
Oncobiologics (OTLK) United States $0.056B 0.00
Applied Genetic Technologies (AGTC) United States $0.056B 30.80
Pluristem Therapeutics (PSTI) Israel $0.055B 0.00
AIT Therapeutics (XAIR) United States $0.055B 0.00
China Health Industries Holdings (CHHE) China $0.054B 20.47
Ophthotech (ISEE) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Evogene (EVGN) Israel $0.040B 0.00
Celsion (CLSN) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
Alimera Sciences (ALIM) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.034B 0.00
VIVUS (VVUS) United States $0.034B 0.00
Proteostasis Therapeutics (PTI) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.033B 0.00
BIOCARDIA INC (BCDA) United States $0.032B 0.00
DiaMedica Therapeutics (DMAC) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.029B 0.20
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Aytu Bioscience (AYTU) United States $0.022B 0.00
VistaGen Therapeutics (VTGN) United States $0.022B 0.00
Vical (VICL) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.07
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) Canada $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00